Profiel
Dr. Christophe Reymond is Chief Scientific Officer at Anergis SA.
Dr. Reymond was previously employed as an Assistant Professor by University of Lausanne, Chief Scientific Officer by Dictagene, and Researcher by University of California San Diego.
Eerdere bekende functies van Christophe Reymond
Bedrijven | Functie | Einde |
---|---|---|
Dictagene | Oprichter | 01-01-2005 |
University of Lausanne | Corporate Officer/Principal | 01-01-2001 |
University of California San Diego | Corporate Officer/Principal | - |
Anergis SA
Anergis SA Pharmaceuticals: GenericHealth Technology Anergis SA develops allergy vaccines. It is a biopharmaceutical company specializing in the discovery and development of novel, proprietary allergy vaccines that target commercially attractive indications and the firm’s vaccines are based on its IP-protected Contiguous Overlapping Peptide technology.The company was founded by Francois Spertini in August 2001 and is headquartered in Epalinges, Switzerland. | Hoofd Techniek/Wetenschap/O&O | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
Anergis SA
Anergis SA Pharmaceuticals: GenericHealth Technology Anergis SA develops allergy vaccines. It is a biopharmaceutical company specializing in the discovery and development of novel, proprietary allergy vaccines that target commercially attractive indications and the firm’s vaccines are based on its IP-protected Contiguous Overlapping Peptide technology.The company was founded by Francois Spertini in August 2001 and is headquartered in Epalinges, Switzerland. | Health Technology |
Dictagene |